Green C, Zaman V, Blumenstock K, Banik N, Haque A
Biomedicines. 2025; 13(1).
PMID: 39857716
PMC: 11763097.
DOI: 10.3390/biomedicines13010132.
Richter E, Geetha T, Burnett D, Broderick T, Babu J
Int J Mol Sci. 2023; 24(5).
PMID: 36902074
PMC: 10002567.
DOI: 10.3390/ijms24054643.
Jalali D, Guevarra J, Martinez L, Hung L, Vonhoff F
Int J Mol Sci. 2021; 22(13).
PMID: 34209883
PMC: 8269328.
DOI: 10.3390/ijms22137022.
Zhang X, Alshakhshir N, Zhao L
Front Neurosci. 2021; 15:662242.
PMID: 33994936
PMC: 8113697.
DOI: 10.3389/fnins.2021.662242.
Swerdlow R, de Leon M, Marcus D
J Alzheimers Dis Rep. 2021; 5(1):135-141.
PMID: 33782666
PMC: 7990458.
DOI: 10.3233/ADR-210002.
Dynamics analysis of the hippocampal neuronal model subjected to cholinergic action related with Alzheimer's disease.
Jiang P, Yang X, Sun Z
Cogn Neurodyn. 2020; 14(4):483-500.
PMID: 32655712
PMC: 7334339.
DOI: 10.1007/s11571-020-09586-6.
CA-30, an oligosaccharide fraction derived from Liuwei Dihuang decoction, ameliorates cognitive deterioration via the intestinal microbiome in the senescence-accelerated mouse prone 8 strain.
Wang J, Lei X, Xie Z, Zhang X, Cheng X, Zhou W
Aging (Albany NY). 2019; 11(11):3463-3486.
PMID: 31160541
PMC: 6594795.
DOI: 10.18632/aging.101990.
Diabetes Mellitus-Related Fractional Glucose Uptake in Men and Women Imaged With F-FDG PET-CT.
Waqas K, van Haard P, Postema J, Schweitzer D
J Endocr Soc. 2019; 3(4):773-783.
PMID: 30963135
PMC: 6446889.
DOI: 10.1210/js.2019-00001.
The effects of perinatal bisphenol A exposure on thyroid hormone homeostasis and glucose metabolism in the prefrontal cortex and hippocampus of rats.
Xu X, Fan S, Guo Y, Tan R, Zhang J, Zhang W
Brain Behav. 2019; 9(3):e01225.
PMID: 30761779
PMC: 6422808.
DOI: 10.1002/brb3.1225.
Therapeutic Advantages of Dual Targeting of PPAR-δ and PPAR-γ in an Experimental Model of Sporadic Alzheimer's Disease.
Reich D, Gallucci G, Tong M, de la Monte S
J Parkinsons Dis Alzheimers Dis. 2019; 5(1).
PMID: 30705969
PMC: 6350901.
DOI: 10.13188/2376-922X.1000025.
Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer's Disease.
Carter C
J Alzheimers Dis Rep. 2018; 1(1):125-157.
PMID: 30480234
PMC: 6159731.
DOI: 10.3233/ADR-170017.
Metabolomic Assays of Postmortem Brain Extracts: Pitfalls in Extrapolation of Concentrations of Glucose and Amino Acids to Metabolic Dysregulation In Vivo in Neurological Diseases.
Dienel G
Neurochem Res. 2018; 44(10):2239-2260.
PMID: 30117094
DOI: 10.1007/s11064-018-2611-y.
Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases.
Di Giovanni G, Strac D, Sole M, Unzeta M, Tipton K, Muck-Seler D
Front Neurosci. 2016; 10:541.
PMID: 27932945
PMC: 5121249.
DOI: 10.3389/fnins.2016.00541.
Long-term high-fat diet induces hippocampal microvascular insulin resistance and cognitive dysfunction.
Fu Z, Wu J, Nesil T, Li M, Aylor K, Liu Z
Am J Physiol Endocrinol Metab. 2016; 312(2):E89-E97.
PMID: 27899343
PMC: 5336564.
DOI: 10.1152/ajpendo.00297.2016.
Targeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies.
Tong M, Dominguez C, Didsbury J, de la Monte S
J Alzheimers Dis Parkinsonism. 2016; 6(3).
PMID: 27525190
PMC: 4979550.
DOI: 10.4172/2161-0460.1000238.
T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.
Tong M, Deochand C, Didsbury J, de la Monte S
J Alzheimers Dis. 2016; 51(1):123-38.
PMID: 26836193
PMC: 5577391.
DOI: 10.3233/JAD-151013.
Microglia-Mediated Inflammation and Neurodegenerative Disease.
Xu L, He D, Bai Y
Mol Neurobiol. 2015; 53(10):6709-6715.
PMID: 26659872
DOI: 10.1007/s12035-015-9593-4.
Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.
Yang S, Li W, Sumien N, Forster M, Simpkins J, Liu R
Prog Neurobiol. 2015; 157:273-291.
PMID: 26603930
PMC: 4871783.
DOI: 10.1016/j.pneurobio.2015.10.005.
Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.
de la Monte S
Curr Alzheimer Res. 2012; 9(1):35-66.
PMID: 22329651
PMC: 3349985.
DOI: 10.2174/156720512799015037.
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease.
de la Monte S
Front Biosci (Elite Ed). 2011; 4(4):1582-605.
PMID: 22201977
PMC: 4550311.
DOI: 10.2741/e482.